Cargando…
CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment
Female breast cancer (BCa) is the most commonly occurring cancer worldwide. The tumor microenvironment (TME) plays an essential role in tumor invasion, angiogenesis, unlimited proliferation, and even immune escape, but we know little about the TME of BCa. In this study, we aimed to find a TME-relate...
Autores principales: | Chen, Yanzhu, Meng, Zhishang, Zhang, Lin, Liu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102873/ https://www.ncbi.nlm.nih.gov/pubmed/33968066 http://dx.doi.org/10.3389/fimmu.2021.664845 |
Ejemplares similares
-
PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma
por: Meng, Zhishang, et al.
Publicado: (2022) -
IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma
por: Liu, Chengdong, et al.
Publicado: (2022) -
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
por: Ottenhof, Sarah Rosanne, et al.
Publicado: (2018) -
Neurotransmitters: promising immune modulators in the tumor microenvironment
por: Xiao, Luxi, et al.
Publicado: (2023) -
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)